1. The 2018 American Academy of Allergy, Asthma & Immunology Foundation Faculty Development awardees 
Zuhair K. Ballas, MD 
Journal of Allergy and Clinical Immunology 
Volume 142, Issue 1, Pages (July 2018)
DOI: /j.jaci
Copyright © Terms and Conditions

2. Fig 1
Sarah E. Henrickson, MD, PhD (left); Lori Broderick, MD, PhD (center); and Adora E. Lin, MD, PhD (right).
Journal of Allergy and Clinical Immunology  , 67-70DOI: ( /j.jaci )
Copyright © Terms and Conditions

3. Fig 2
Research by Dr Henrickson. In certain PID, there is an imbalance in baseline T cell signaling between CD28 (stimulatory) and CTLA-4 (inhibitory) signals and this leads to chronic increased signaling: A) homeostasis; B) less negative signal; C) more positive signal. CTLA-4, Cytotoxic T lymphocyte–associated antigen 4; mTOR, mechanistic target of rapamycin; PI3K, phosphoinositide 3-kinase; TCR, T-cell receptor.
Journal of Allergy and Clinical Immunology  , 67-70DOI: ( /j.jaci )
Copyright © Terms and Conditions

4. Fig 3 Graphical abstract: Research by Dr Broderick.
Journal of Allergy and Clinical Immunology  , 67-70DOI: ( /j.jaci )
Copyright © Terms and Conditions

5. Fig 4 Graphical abstract: Research by Dr Lin.
Journal of Allergy and Clinical Immunology  , 67-70DOI: ( /j.jaci )
Copyright © Terms and Conditions